Bibliography | 1.Toll-like receptors and cancer, particularly oral squamous cell carcinoma.Rich AM, Hussaini HM, Parachuru VP, Seymour GJ.Front Immunol. 2014; 5():464. 2.Opsal MA, Våge DI, Hayes B, Berget I, Lien S. Genomic organization and transcript profiling of the bovine toll-like receptor gene cluster TLR6-TLR1-TLR10. Gene. 2006 Dec 15;384:45-50. doi: 10.1016/j.gene.2006.06.027. Epub 2006 Jul 29. PMID: 16950576. 3.Semlali A, Reddy Parine N, Arafah M, Mansour L, Azzi A, Al Shahrani O. et al. Expression and Polymorphism of Toll-Like Receptor 4 and Effect on NF-kappaB Mediated Inflammation in Colon Cancer Patients. PLoS One. 4.Gu J, Liu Y, Xie B, Ye P, Huang J, Lu Z. Roles of toll-like receptors: From inflammation to lung cancer progression. Biomed Rep. 2018;8:126–32. 2016;11:e0146333. 5.Bhatelia K, Singh K, Singh R. TLRs: linking inflammation and breast cancer. Cell Signal. 2014;26:2350–7. 6.Liu YD, Ji CB, Li SB, Yan F, Gu QS, Balic JJ. et al. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-kappaB signaling pathways. Int Immunopharmacol. 2018;59:375–83. 7. Xu C, Li H, Yin M, Yang T, An L, Yang G. Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis. Oncotarget. 2017;8:98394–404. |